Interaction Checker

Two hormonal therapies for prostatic neoplasms now available on the interaction checker

Monday 18 December 2017

Abiraterone and enzalutamide are now listed in the interaction checker as cancer drugs and interactions can be found for all the comedications. 

• Abiraterone (Zytiga®) is an androgen biosynthesis inhibitor and is indicated for the treatment of prostatic neoplasms. 
• Enzalutamide (Xtandi®) is an androgen receptor inhibitor and is indicated for the treatment of prostatic neoplasms. 

ENDORSED BY
Bopa